«Dendritic Cells

Below is an extended Dendritic Cells patents listing. Click here to return to the Dendritic Cells main in depth entry.

Patents :
US Patent No.	Title
7423142	Compositions and methods for inhibiting expression of anti-apoptotic genes
7425606	Method for screening peptides for use in immunotherapy
7425607	Compositions comprising a lung tumor antigen
7425609	PRO4330 polypeptides
7425610	Methods and materials relating to CD84-like polypeptides and polynucleotides
7425611	Immunogenic HIV-1 multi-clade, multivalent constructs and methods of their use
7425612	Genes and polypeptides relating to human colon cancers
7425619	Fc.gamma.RIIB specific antibodies and methods of use thereof
7425620	Fc.gamma.RIIB-specific antibodies and methods of use thereof
7425621	Antibodies against the PRO4401 polypeptide
7425622	Antibodies against C3a receptor
7425605	PRO1486 polypeptides
7425545	Modulation of C-reactive protein expression
7425543	Microencapsulated materials and method of making same
7425325	Cytokine zcytor17 ligand polypeptides
7425332	Treatment of autoimmune conditions with Copolymer 1 and related Copolymers
7425337	Alphavirus replicon vector systems
7425339	CD8alpha mutants
7425410	Methods for diagnosing a bipolar disorder and unipolar disorder
7425429	Method for the identification of tissue-specific regulatory sequences
7425444	Circovirus sequences associated with piglet weight loss disease (PWD)
7425445	Modulators that promote cell surface expression of odorant receptors
7425447	Host cells expressing 7C10 and 16C10 CD80-specific antibodies
7425532	Use of alanyl aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors
7426440	Repair and protection factor scoring method for bioactive agents
7427397	Probiotic propionibacterium
7427668	Antibodies binding the TNF related protein, TNF-Y
7429376	Methods of screening for compounds that improve engraftment
7429383	Parathyroid hormone receptor activation and hematopoietic progenitor cell expansion
7429461	Genetic products differentially expressed in tumors and use thereof
7429489	Methods of controlling proliferation and differentiation of stem and progenitor cells
7429591	Substituted pyrazoles
7429639	SSX-2 peptides presented by HLA class II molecules
7429640	PRO6181 polypeptides
7429641	PRO9830 polypeptides
7429645	Humanized anti-lymphotoxin beta receptor antibodies
7427667	PRO9835 antibodies
7427665	Chronic lymphocytic leukemia cell line
7427655	Synthetic immunogenic but non amyloidogenic peptides homologous to amyloid .beta. for induction of an immune response to amyloid .beta. and amyloid deposits
7427399	Antibodies and related molecules that bind to 161P2F10B proteins
7427401	Method of modulating leukemic cell and eosinphil activity with monoclonal antibodies
7427402	Method of evaluating inflammatory skin disorders using IL-17 and/or IL-19
7427405	Immunostimulatory oligonucleotide multimers
7427469	Method of treating cytomegalovirus with DC-SIGN blockers
7427502	Methods for identifying stem cells based on nuclear morphotypes
7427600	Active agent delivery systems and methods for protecting and administering active agents
7427606	Method to reduce inflammatory response in transplanted tissue
7427616	Condensed pyridines and pyrimidines with tie2 (TEK) activity
7427629	Immunostimulatory compositions and methods of stimulating an immune response
7429646	Antibodies to human tumor necrosis factor receptor-like 2

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.